Bioray Biotech Co

Bioray Biotech Co Book Value per Share

The Book Value per Share of Bioray Biotech Co (7561.TWO) as of Oct 20, 2026 is 15.06 TWD. In the previous year, Book Value per Share was 13.98 TWD — a change of 7.67% (higher).

Book Value per Share

15.06TWD

YoY

7.67%

Last updated:

Book Value per Share of Bioray Biotech Co is 2025 15.06 TWD. Book Value per Share of Bioray Biotech Co was 2024 13.98 TWD. It decreases by 7.67% higher compared to the previous year.

The Bioray Biotech Co Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2018
12.38 TWD
Jan 1, 2019
12.56 TWD
Jan 1, 2020
12.28 TWD
Jan 1, 2021
12.09 TWD
Jan 1, 2022
15.00 TWD
Jan 1, 2023
14.42 TWD
Jan 1, 2024
13.98 TWD
Jan 1, 2025
15.06 TWD
The Bioray Biotech Co Book Value per Share history
YEARBook Value per ShareYoY
15.06TWD+7.67%
13.98TWD-3.03%
14.42TWD-3.89%
15.00TWD+24.06%
12.09TWD-1.48%
12.28TWD-2.24%
12.56TWD+1.45%
12.38TWD+69.88%
7.29TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bioray Biotech Co Stock analysis

What does Bioray Biotech Co do? BioRay Biotech Co., Ltd. generates revenue through its biological health products, functional medical testing services, and cell storage and preparation offerings. The company sells personalized probiotics, anti-allergic and intestinal probiotics, diabetes probiotics, female urinary tract products, and anti-arthritis probiotics. Functional medical testing includes personalized bacteria, personalized fungi, intestinal normal bacteria, quantitative magnesium detection in red blood cells, metabolic gene polymorphism analysis, and lymphocyte grouping. Cell storage services feature stem cell storage, immune cell storage, and cytokine induced killer (CIK) immune cell preparations. The primary customers for these products and services are individuals seeking personalized health solutions, including those managing chronic conditions like diabetes or arthritis. The company targets health-conscious consumers and medical professionals requiring specialized testing and cell-based therapies. BioRay Biotech focuses on delivering tailored health and medical services through its integrated product and service portfolio. Revenue streams are derived from direct sales of health products, testing service fees, and cell storage contracts. The business model emphasizes customization, with each product and service segment catering to specific health needs. The company’s offerings are structured to address individual health challenges through scientific and personalized approaches. Bioray Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bioray Biotech Co stock

Book Value per Share of Bioray Biotech Co is 15.06 TWD in 2025.

Book Value per Share of Bioray Biotech Co changed from 13.98 TWD to 15.06 TWD, representing a 7.67% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share Bioray Biotech Co since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Bioray Biotech Co

All Key Metrics — Bioray Biotech Co